IMCC

IM Cannabis Corp. (IMCC) SWOT Analysis Analysis (2026)

Invetso Score: 3/10 — Weak · Last Updated: 2026-09-01

Monthly Update

No material changes this month.

Strengths

Score: 4.6 (Moderate)

Asset-light cannabis branding and retail exposure can support consumer recognition, but peers with larger scale and stronger balance sheets still convert it into profits more reliably.

A positive cash conversion cycle of 11.8 days indicates working-capital discipline, yet peers with stronger liquidity profiles retain more flexibility through industry volatility.

Negative ROIC of -0.9% is still better than many distressed cannabis operators, but it remains structurally below profitable peers that compound capital more effectively.

Weaknesses

Score:

Net debt to EBITDA of 22.2x signals severe leverage, leaving IM Cannabis far weaker than better-capitalized peers that can fund operations without refinancing pressure.

Current and quick ratios below 1.0 indicate tight liquidity, so IM Cannabis trails peers with stronger near-term solvency and greater resilience to demand shocks.

Negative ROIC shows capital is not earning its cost, which keeps IM Cannabis behind peers that can reinvest internally and widen competitive gaps.

High debt-to-equity of 4.4x constrains strategic optionality, whereas less levered peers can absorb margin volatility and pursue growth more safely.

Opportunities

Score:

If cannabis market normalization improves pricing discipline, IM Cannabis could benefit, but peers with stronger balance sheets would likely capture the upside faster.

Working-capital efficiency already looks better than many peers, so incremental operational improvements could modestly support liquidity and reduce dependence on external funding.

Any regulatory easing in core markets could expand legal demand, yet larger peers with broader distribution and capital access would still be positioned to scale first.

Threats

Score:

Persistent leverage and weak liquidity increase refinancing risk, making IM Cannabis more vulnerable than peers with investment-grade-like balance sheets in a capital-constrained sector.

Industry price compression can quickly erode margins, and weaker operators like IM Cannabis typically lose share to better-funded peers during downturns.

Negative returns on capital raise the risk of value destruction if competitive intensity stays high, while stronger peers can sustain investment through the cycle.

Overall Score

Score:

IM Cannabis is structurally weaker than peers because leverage, liquidity, and subpar capital returns outweigh limited working-capital discipline and any optionality from market recovery.

Sources

  • Company filings (10-K, 10-Q, investor presentations)
  • Financial and market data providers
  • Public news and industry information

🔒 Go Beyond This Framework

This is one of 10 institutional-grade frameworks Invetso runs on IM Cannabis Corp.. Unlock the complete analysis — SWOT, Economic Moat, Porter’s Five Forces, Management, PESTLE and the Invetso Quality Score.

Create your free account on Invetso →

Invetso is not affiliated with or regulated by the U.S. Securities and Exchange Commission (SEC), the Financial Industry Regulatory Authority (FINRA), or any other financial regulatory authority. The analyses, scores and all the information provided by Invetso are strictly for informational purposes only and do not constitute financial advice, recommendations, or an offer to buy or sell any securities. Invetso is not a registered financial advisor, broker-dealer, or investment advisor, and it does not provide personalized investment, legal, or tax advice. The content provided on this website is not intended to serve as a substitute for professional advice. Users should conduct their own research and consult with a qualified financial advisor before making any investment decisions. All analysis, data, and information presented on this site are based on publicly available information and should be used at the user’s own risk. Invetso does not guarantee the accuracy, completeness, or timeliness of any information or data provided, nor does it endorse any specific securities, companies, or strategies. Any reliance you place on such information is strictly at your own risk. While we strive to provide accurate and up-to-date information, Invetso makes no warranties or representations regarding the completeness, accuracy, or reliability of any analyses or data on our platform, and any such information is subject to the terms and conditions of the Invetso Terms of Service. Our analyses are generated using AI technologies and AI-generated content may contain errors or inaccuracies. Use the information at your own risk. Our platform may contain links to third-party websites, for which we are not responsible for the content or accuracy of information. Invetso shall not be liable for any loss or damage arising from the use of our services. By using this website, you agree that Invetso is not responsible for any losses, damages, or financial outcomes that may result from your use of the information, tools, or resources provided. We recommend consulting with a licensed financial professional before making any investment decisions.

For more details, please refer to our Terms of Service and Privacy Policy.